Dr. Park, Assistant Professor in the Department of Bioengineering at CU Denver, receives NIH R21 grant

Dr. Park, Assistant Professor in the Department of Bioengineering at CU Denver, receives NIH R21 grant ($406,500) from National Heart, Lung, and Blood Institute. His project title is “A biomimetic reverse thermal gel for the treatment of myocardial infarction”. NIH will support this research for two years.

Myocardial infarction (MI) is a leading coronary artery disease caused by the death of heart muscle tissues. The aim of this research is to develop new methodology to treat MI using a synthetic growth factor (GF) delivery system that 1) mimics biofunction of natural heparin, 2) achieves sustained and localized GF expression and 3) promotes angiogenesis in the infarction site and thereby enhances MI treatment effect.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s